Alzheimers Drug Discovery Foundation
93% goes to programs $11 to raise $100 Strong reserves
Alzheimers Drug Discovery Foundation is a 501(c)(3) organization based in New York, New York, registered in 2005, with $47,282,987 in FY2024 revenue. CharityIndex grades it C, and it directs about 93% of spending to programs.
57 W 57th St Ste 904, New York, NY, 10019 EIN 20-1082179 Since 2005
Revenue (FY2024)
$47.3M
▲ 25.3% vs prior year
Social Science median: $380K
Expenses (FY2024)
$88.3M
Net assets
$217.0M
Employees
48
CharityIndex rating
One independent A+ to F grade from four published criteria, each scored separately from IRS filings and combined by weight.
C
★★★★
Rated on 4 of 4 criteria.
Held down by its weakest criterion — a strong score on one criterion can't hide a weak one.
How the rating works →A+Program efficiency40% of the rating93% to programs · $11 to raise $100
Measures how much of every dollar spent actually reaches programs, plus what it costs to raise $100 of donations. The worse of the two measures sets the letter (85%+ to programs is an A; under $15 to raise $100 is an A), averaged over the three most recent filings. For Alzheimers Drug Discovery Foundation: 93% to programs · $11 to raise $100 earns a A+ on this criterion. See the exact thresholds →
FFinancial health25% of the rating30 mo reserves · -87% margin
Measures whether the organization is built to last: how many months its reserves would cover expenses (3+ months earns an A-range score, but hoarding 5+ years of budget is capped) and whether it runs a surplus or a deficit. For Alzheimers Drug Discovery Foundation: 30 mo reserves · -87% margin earns a F on this criterion. See the exact thresholds →
A+Governance25% of the rating6 of 6 checks met
Checks how the organization is run, from its own Form 990: an independent board majority, a board of five or more, conflict-of-interest, whistleblower and document-retention policies, and independently audited financials. The share of disclosed checks that pass sets the letter. For Alzheimers Drug Discovery Foundation: 6 of 6 checks met earns a A+ on this criterion. See the exact thresholds →
ATransparency10% of the rating4 of 5 disclosure signals
Counts five disclosure signals: a recent filing, a mission statement, program descriptions, a listed website, and the full expense breakdown. More disclosure, better letter. For Alzheimers Drug Discovery Foundation: 4 of 5 disclosure signals earns a A on this criterion. See the exact thresholds →
Show this grade on your website
A live seal — it updates automatically when the grade changes and links donors to this verified profile.
Mission
Accelerate the discovery of drugs to prevent and treat alzheimer's disease and related dementias.
Contact & location
- Address
- 57 W 57th St Ste 904, New York, NY, 10019
- City
- New York
- State
- New York
- Category
- Social Science
- Subcategory
- Interdisciplinary Research
- Phone
- …
- Website
- …
Financial trends
Revenue grew from $9.3M (FY2013) to $47.3M (FY2024) across 12 reported years.
Financial snapshot
Financial health & position (FY2024)
Liabilities $82.4MNet assets $217.0M
Operating margin
-86.6%
Spent more than it raised in the latest fiscal year.
Total assets
$299.4M
Total liabilities
$82.4M
Net assets
$217.0M
Salaries & benefits
$8.9M
10% of expenses
Board members
29
28 independent
Financials by year
| Fiscal year | Revenue | Expenses | Net assets | Total assets | Form |
|---|---|---|---|---|---|
| 2024 | $47,282,987▲25.3% | $88,250,427▲42.5% | $216,976,767▼16.5% | $299,394,693▼7.6% | 990 |
| 2023 | $37,742,020▼85.1% | $61,943,588▲68.1% | $259,990,581▼8.3% | $324,173,528▼4.7% | 990 |
| 2022 | $254,027,105▲379% | $36,842,901▼0.8% | $283,512,174▲343% | $340,253,841▲192% | 990 |
| 2021 | $53,037,104▲91.9% | $37,126,176▲31.4% | $64,041,673▲30.0% | $116,420,075▲19.6% | 990 |
| 2020 | $27,631,350▲21.7% | $28,251,909▼12.9% | $49,280,564▼1.9% | $97,381,722▲0.2% | 990 |
| 2019 | $22,712,391▼59.3% | $32,429,304▲100% | $50,216,968▼16.2% | $97,175,562▲7.9% | 990 |
| 2018 | $55,817,240▲286% | $16,190,686▼8.8% | $59,933,881▲195% | $90,038,223▲95.8% | 990 |
| 2017 | $14,478,811▼37.2% | $17,762,480▲4.4% | $20,307,327▼13.9% | $45,973,409▲1.3% | 990 |
| 2016 | $23,050,881▲3.2% | $17,010,961▲29.5% | $23,590,996▲34.6% | $45,379,428▲45.8% | 990 |
| 2015 | $22,345,751▲86.7% | $13,140,852▲31.2% | $17,521,699▲107% | $31,129,927▲61.3% | 990 |
| 2014 | $11,968,562▲28.8% | $10,012,318▲29.9% | $8,462,638▲30.1% | $19,304,546▲31.5% | 990 |
| 2013 | $9,290,907 | $7,707,649 | $6,506,394 | $14,685,410 | 990 |
Original Form 990 PDFs (the Form column) are served by ProPublica Nonprofit Explorer, as filed with the IRS. Create a free account to download the CSV report.
Leadership & compensation (FY2024)
Highest-paid: Howard Fillit Md — $663,174 (0.75% of total expenses)
| Name | Title | Hours/week | Compensation |
|---|---|---|---|
| Howard Fillit Md | Founding Exec. Dir. & Chief Science Off. | 40 | $663,174 |
| Mark Roithmayr | Ceo | 40 | $651,120 |
| Laura Nisenbaum | Executive Director, Drug Development | 40 | $442,772 |
| Jane Mcintosh | Chief External Affairs | 40 | $377,792 |
| Karen Harris | Cfo and Head of Mission Related Inv | 40 | $369,039 |
| Aaron Burstein | Head of Search and Evaluation | 40 | $314,231 |
| Eli Shobin | Senior Director Dxa | 40 | $235,962 |
| Lakita Cavin | Attorney, Mission-related | 40 | $220,246 |
| Adam Hoffman | Governor | 1 | — |
| Alice Shure | Governor | 1 | — |
| Ann Jackson | Governor | 1 | — |
| Bonnie Englebardt Lautenberg | Governor | 1 | — |
| Bonnie Pfeifer Evans | Governor | 1 | — |
| Carol Boulanger | Governor | 1 | — |
| David Weinreb | Governor | 1 | — |
| Gary M Lauder | Governor | 1 | — |
| Henrik Zetterberg Md Phd | Governor | 1 | — |
| Julieann Shanahan Cfa | Governor | 1 | — |
| Lanny Edelsohn Md | Governor | 1 | — |
| Laura Steele | Governor | 1 | — |
Top vendors & contractors (FY2024)
| Contractor | Services | Paid |
|---|---|---|
| Arabella Advisors LLC | Consulting Services | $266,096 |
| Russo Partners LLC | Public Relations | $219,347 |
| Craft & Commerce LLC | Marketing Services | $137,939 |
| Allan M Green Md Phd Ld | Legal Services | $115,020 |
Grants received · $46.5M total
153 grants to Alzheimers Drug Discovery Foundation totaling $46.5M, reported by foundations on their Schedule I filings — showing the 15 most recent.
| Grantmaker | Purpose | Year | Amount |
|---|---|---|---|
| Foundation For the Carolinas | Charitable gift | 2024 | $200,000 |
| American Endowment Foundation | Social sciences | 2024 | $100,750 |
| American Online Giving Foundation Inc | General support | 2024 | $70,488 |
| Morgan Stanley Global Impact Funding Trust Inc | Unrestricted general support | 2024 | $65,000 |
| Morgan Stanley Global Impact Funding Trust Inc | Unrestricted general support | 2024 | $55,000 |
| The Bessemer Giving Fund | General support | 2024 | $35,000 |
| Jewish Communal Fund | In furtherance of grantee's tax-exempt purpose | 2024 | $34,110 |
| Silicon Valley Community Foundation | Health | 2024 | $30,000 |
| The Us Charitable Gift Trust | For recipient's exempt purpose | 2024 | $25,800 |
| Raymond James Charitable Endowment Fund | General support | 2024 | $17,000 |
| Greater Horizons | Health, medicine & science | 2024 | $15,000 |
| The New York Community Trust | For general support. | 2024 | $14,750 |
| National Christian Charitable Foundation | Medical research | 2024 | $10,000 |
| The New York Community Trust | For program support. | 2024 | $10,000 |
| Paypal Charitable Giving Fund | General support | 2024 | $5,764 |
Grants made · $54.8M in FY2024
26 grants totaling $54.8M in FY2024 — showing the 15 largest. All grants made by Alzheimers Drug Discovery Foundation →
| Recipient | Purpose | Amount |
|---|---|---|
| Alamar Biosciences | Alzheimers research | $10,016,094 |
| C2n Diagnostics | Alzheimers research | $7,025,121 |
| Pharmatrophix | Alzheimers research | $5,609,700 |
| Metro International Biotechedenroc | Alzheimers research | $5,000,000 |
| Coya Therapeutics | Alzheimers research | $5,000,000 |
| Modulo Bio Inc | Alzheimers research | $4,845,794 |
| Board of Regents Nevada System of Higher Education | Alzheimers research | $3,247,762 |
| Aquinnah Pharmaceuticals | Alzheimers research | $2,999,586 |
| Davos Alzheimers Collaborative Inc | Alzheimers research | $2,500,000 |
| University of Arizona - Health Sciences | Alzheimers research | $1,774,201 |
| Vaccinex | Alzheimers research | $1,750,000 |
| Viewmind | Alzheimers research | $1,429,119 |
| Esya Inc | Alzheimers research | $789,000 |
| Trustees of Indiana University | Alzheimers research | $599,920 |
| University of Minnesota | Alzheimers research | $493,875 |
Similar organizations in Social Science
Social Science
Global Poverty Project Inc
New York, NY
$45.1M
Aannual revenue
Social Science
Innovations For Poverty Action
New York, NY
$52.8M
C+annual revenue
Social Science
Social Science Research Council
Brooklyn, NY
$16.7M
C+annual revenue
Social Science
American Federation For Aging
New York, NY
$15.9M
C+annual revenue
Social Science
Nextcorps Inc
Rochester, NY
$13.6M
Bannual revenue
Social Science
Just Capital Foundation Inc
New York, NY
$11.8M
Bannual revenue
Social Science
Association of the Bar of the City of New York Fund Inc
New York, NY
$9.7M
Bannual revenue
Social Science
Common Justice
Brooklyn, NY
$7.4M
Bannual revenue
Social Science
Council For Economic Education
New York, NY
$6.9M
Bannual revenue
- Social Science
Inside Climate News
Brooklyn, NY
$6.6M
Bannual revenue
Compare Alzheimers Drug Discovery Foundation
Frequently asked questions
- Is Alzheimers Drug Discovery Foundation a legitimate nonprofit?
- Yes. Alzheimers Drug Discovery Foundation is a 501(c)(3) organization registered with the U.S. Internal Revenue Service under EIN 20-1082179, based in New York, New York. Donations are tax-deductible.
- What is Alzheimers Drug Discovery Foundation's EIN?
- Alzheimers Drug Discovery Foundation's Employer Identification Number (EIN) is 20-1082179.
- How much revenue does Alzheimers Drug Discovery Foundation report?
- Alzheimers Drug Discovery Foundation reported $47,282,987 in total revenue on its fiscal year 2024 IRS Form 990 filing.
- How much of Alzheimers Drug Discovery Foundation's spending goes to programs?
- Alzheimers Drug Discovery Foundation spends about 93% of its total expenses on programs, based on its latest IRS Form 990.
- What financial grade does Alzheimers Drug Discovery Foundation have?
- CharityIndex grades Alzheimers Drug Discovery Foundation C, based on program efficiency and fundraising cost.
- How much does Alzheimers Drug Discovery Foundation's highest-paid employee make?
- The highest reported compensation on Alzheimers Drug Discovery Foundation's latest Form 990 is $663,174, paid to Howard Fillit Md (Founding Exec. Dir. & Chief Science Off.).
More nonprofits in New York
Explore more
Data for Alzheimers Drug Discovery Foundation (EIN 20-1082179) comes from the IRS Business Master File and e-filed Form 990 returns, via CharityIndex. Figures reflect what the organization reported to the IRS for each fiscal year.